• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基底样型和三阴性乳腺癌:批判性综述,重点关注对病理学家和肿瘤学家的影响。

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.

机构信息

Clarian Pathology Lab, Department of Pathology and Internal Medicine, Indiana University, Indianapolis, USA.

出版信息

Mod Pathol. 2011 Feb;24(2):157-67. doi: 10.1038/modpathol.2010.200. Epub 2010 Nov 12.

DOI:10.1038/modpathol.2010.200
PMID:21076464
Abstract

Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct morphological features and clinical behaviors. Although morphology is often associated with the pattern of molecular aberrations in breast cancers, it is also clear that tumors of the same histological type show remarkably different clinical behavior. This is particularly true for 'basal-like cancer', which is an entity defined using gene expression analysis. The purpose of this article was to review the current state of knowledge of basal-like breast cancers, to discuss the relationship between basal-like and triple-negative breast cancers, and to clarify practical implications of these diagnoses for pathologists and oncologists.

摘要

乳腺癌是一种异质性疾病,包含多种具有不同形态特征和临床行为的实体。尽管形态学通常与乳腺癌中分子异常的模式相关,但也很明显,同一组织学类型的肿瘤表现出明显不同的临床行为。这在“基底样癌”中尤其如此,它是一种使用基因表达分析定义的实体。本文的目的是综述基底样乳腺癌的当前知识状态,讨论基底样和三阴性乳腺癌之间的关系,并阐明这些诊断对病理学家和肿瘤学家的实际意义。

相似文献

1
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.基底样型和三阴性乳腺癌:批判性综述,重点关注对病理学家和肿瘤学家的影响。
Mod Pathol. 2011 Feb;24(2):157-67. doi: 10.1038/modpathol.2010.200. Epub 2010 Nov 12.
2
Triple negative tumours: a critical review.三阴性肿瘤:一项批判性综述。
Histopathology. 2008 Jan;52(1):108-18. doi: 10.1111/j.1365-2559.2007.02889.x.
3
Triple-negative/basal-like breast cancer: review.三阴性/基底样乳腺癌:综述
Pathology. 2009 Jan;41(1):40-7. doi: 10.1080/00313020802563510.
4
Association between mammographic density and basal-like and luminal A breast cancer subtypes.乳腺钼靶密度与基底样和腔面A型乳腺癌亚型之间的关联。
Breast Cancer Res. 2013;15(5):R76. doi: 10.1186/bcr3470.
5
Triple-negative breast cancer: current state of the art.三阴性乳腺癌:当前的技术水平
Tumori. 2010 Nov-Dec;96(6):875-88.
6
Pharmacotherapy of triple-negative breast cancer.三阴性乳腺癌的药物治疗
Expert Opin Pharmacother. 2009 Sep;10(13):2081-93. doi: 10.1517/14656560903117309.
7
Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features.乳腺癌基底样亚型的形态学特征,特别提及细胞病理学特征。
Breast Cancer. 2009;16(3):179-85. doi: 10.1007/s12282-009-0108-x. Epub 2009 May 23.
8
p16INK4a expression in basal-like breast carcinoma.p16INK4a在基底样乳腺癌中的表达。
Int J Clin Exp Pathol. 2010 Jun 30;3(6):600-7.
9
[Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].[免疫组织化学在基底样乳腺癌预后评估中的作用]
Zhonghua Bing Li Xue Za Zhi. 2009 Jan;38(1):23-8.
10
Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.波形蛋白、zeb1 和 Sip1 在三阴性和基底样乳腺癌中上调:与侵袭性肿瘤表型相关。
Breast Cancer Res Treat. 2013 Feb;138(1):81-90. doi: 10.1007/s10549-013-2442-0. Epub 2013 Feb 15.

引用本文的文献

1
Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers.心理应激生物标志物与BRCA1/2突变携带者患乳腺癌和前列腺癌的易感性增加有关。
Br J Cancer. 2025 Jul 2. doi: 10.1038/s41416-025-03085-3.
2
Autophagy-targeted NBR1-p62/SQSTM1 complexes promote breast cancer metastasis by sequestering ITCH.自噬靶向的NBR1-p62/SQSTM1复合物通过隔离ITCH促进乳腺癌转移。
Nat Cell Biol. 2025 Jun 27. doi: 10.1038/s41556-025-01689-8.
3
Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action.
治疗雌激素受体阳性乳腺癌:当前美国食品药品监督管理局批准的选择性雌激素受体调节剂和选择性雌激素受体下调剂及其作用机制综述
Oncol Rev. 2025 Apr 10;19:1564642. doi: 10.3389/or.2025.1564642. eCollection 2025.
4
Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives.三阴性乳腺癌中的细胞外囊泡和基于微小RNA的疗法:进展与临床前景
Extracell Vesicles Circ Nucl Acids. 2025 Feb 14;6(1):54-71. doi: 10.20517/evcna.2024.85. eCollection 2025.
5
Tumor Microenvironment Dynamics of Triple-Negative Breast Cancer Under Radiation Therapy.三阴性乳腺癌在放射治疗下的肿瘤微环境动态变化
Int J Mol Sci. 2025 Mar 20;26(6):2795. doi: 10.3390/ijms26062795.
6
Correlation between BRCA1 expression and the advanced stage of triple‑negative breast cancer.BRCA1表达与三阴性乳腺癌晚期之间的相关性。
Mol Clin Oncol. 2025 Jan 30;22(4):32. doi: 10.3892/mco.2025.2827. eCollection 2025 Apr.
7
Adenoid cystic carcinoma of the breast, from diagnosis to management: a case report.乳腺腺样囊性癌:从诊断到治疗——病例报告
J Med Case Rep. 2025 Jan 3;19(1):1. doi: 10.1186/s13256-024-04995-1.
8
Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escape.埃塞俄比亚乳腺癌患者的血液免疫图谱揭示了不同形式的免疫逃逸。
Oncoimmunology. 2024 Dec 31;13(1):2436227. doi: 10.1080/2162402X.2024.2436227. Epub 2024 Dec 2.
9
β-integrin controls IGF-1R internalization and intracellular signaling.β-整合素调控胰岛素样生长因子-1受体(IGF-1R)的内化及细胞内信号传导。
J Biol Chem. 2025 Jan;301(1):108021. doi: 10.1016/j.jbc.2024.108021. Epub 2024 Nov 27.
10
Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.ICAM-1 在三阴性乳腺癌转移进展中的肿瘤内在作用,通过与 EGFR 的直接相互作用。
Mol Cancer. 2024 Oct 16;23(1):230. doi: 10.1186/s12943-024-02150-4.